Discoveries and treatments for brain conditions

Brain conditions, including Parkinson’s disease, stroke, epilepsy and mental illness, are chronic afflictions that diminish a person’s quality of life. The conditions affect one in five Americans. The social and economic impacts are devastating, with annual U.S. health care and lost productivity costs estimated at nearly $500 billion.  Through high-impact research and discovery in the field of neuromodulation, MnDRIVE trains the next generation of scientists and clinicians, and brings new and improved therapies to Minnesotans suffering from brain conditions. The initiative will expand University partnerships with industries to bring neuromodulation innovations to market, which benefits patients and advances the state’s economy.

Funding Opportunities

2018 - 2019 MnDRIVE Fellowships in Neuromodulation

January 19, 2018

(summer 2018 and fall 2018 start dates)


Check out the latest news from the Spring, 2017 Neurosciences News

University of Minnesota named a Udall Center for Excellence in Parkinson’s Disease Research, receives $9.07 million from NIH over five years

Dr. Jerrold Vitek, MD, PhD,   Head of Neurology and member of the MnDRIVE Brain Conditions leadership team, will direct the Udall Center.   “Legislative support through the MnDRIVE Brain Conditions initiative helped set the stage for the Udall Center,” said Vitek. “We are especially grateful to the people of Minnesota and the state legislature. We are committed to serving as a resource for patients and their families throughout the state as a return on this investment.”

Possible link between Parkinson's disease and sleep disorders

MnDRIVE researcher Colum MacKinnon, Ph.D., is studying a link between Parkinson's disease and sleep problems. 

MinnPost: Psychological impact of brain injuries can be long-lasting

MinnPost – March 11, 2016. Kelvin Lim, M.D., a MnDRIVE researcher, discusses traumatic brain injuries.

MinnPost: Research may identify relapse trigger in human brain

MinnPost – February 25, 2016. Neuroscientists at the University have found a cell group associated with opioid relapse.